Clinical trial
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
NCT00004288 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 1996
- Completion date
- December 31, 1999
- Enrollment
- 4
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis